Table 1.
Group | 1 | 2a | 2b |
---|---|---|---|
Parameter | Controls (n = 11) | PAH (n = 19) | PAH (n = 79) |
Systolic PA pressure (P sys), mmHg | 32 ± 6 | 86 ± 18* | 81 ± 22* |
Diastolic PA pressure (P dia), mmHg | 13 ± 4 | 36 ± 9* | 30 ± 10* |
Mean PA pressure (P mean), mmHg | 21 ± 4 | 55 ± 11* | 50 ± 13* |
Ratio K sys (P sys/P mean) | 1.52 ± 0.15 | 1.57 ± 0.13 | 1.59 ± 0.16 |
Ratio K dia (P dia/P mean) | 0.58 ± 0.10 | 0.65 ± 0.07 | 0.59 ± 0.09 |
Characteristic impedance (Z 0), mmHg s/mL | 0.05 ± 0.01 | 0.11 ± 0.05* | Not determined |
Peripheral resistance (R p), mmHg s/mL | 0.30 ± 0.08 | 0.90 ± 0.37* | Not determined |
Total vascular resistance (R T), mmHg s/mL | 0.32 ± 0.09 | 1.01 ± 0.39* | Not determined |
Arterial compliance (C a), mL/mmHg | 5.85 ± 2.71 | 0.98 ± 0.53 * | Not determined |
Inverse arterial compliance (1/C a), mmHg/mL | 0.35 ± 0.13 | 1.37 ± 0.77* | Not determined |
R T C a-time, s | 0.82 ± 0.24 | 0.76 ± 0.29 | Not determined |
End-systolic elastance (E es), mL/mmHg | 0.44 ± 0.41 | 1.51 ± 0.87* | Not determined |
End-diastolic elastance (E ed), mL/mmHg | 0.01 ± 0.03 | 0.06 ± 0.06 | Not determined |
Intercept volume (V 0), mL | −50 ± 106 | 71 ± 87* | Not determined |
Time to reach E es (t es), s | 0.33 ± 0.04 | 0.35 ± 0.07 | Not determined |
Heart rate (HR), beats/min | 77 ± 13 | 83 ± 15 | 80 ± 16 |
Filling pressure (P v), mmHg | 6.5 ± 7.0 | 7.9 ± 6.0* | Not determined |
End-diastolic volume (V ed), mL | 103 ± 64 | 173 ± 63* | Not determined |
Peak isovolumic pressure (P max), mmHg | 48 ± 14 | 124 ± 47* | Not determined |
Stroke volume (V s), mL | 68 ± 17 | 46 ± 18* | Not determined |
Values are mean ± SD. Group 1 consists of non-PH patients and served as the control group (see text). Group 2a consists of PAH patients in whom all model parameters were estimated for comparison with control values (i.e. to obtain the physiological variation). Group 2b consists of PH patients who were included to increase the total number of patients to compare individual hemodynamical measurements
* Significantly different compared to control subjects (p < 0.05)